OrthoPediatrics Corp.

Symbol: KIDS




Market price today

  • -34.7821

    P/E Ratio

  • -1.9357

    PEG Ratio

  • 796.60M

    MRK Cap

  • 0.00%

    DIV Yield

OrthoPediatrics Corp. (KIDS) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. David R. Bailey
Full-time employees:247
Address:2850 Frontier Drive

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

General Outlook

When we look at how much money they make before expenses, they keep 0.707% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.172%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.136%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.050% return, is a testament to OrthoPediatrics Corp.'s adeptness in optimizing resource deployment. OrthoPediatrics Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.059%. Furthermore, the proficiency of OrthoPediatrics Corp. in capital utilization is underscored by a remarkable -0.071% return on capital employed.

Liquidity Ratios

Analyzing KIDS liquidity ratios reveals its financial health of the firm. The current ratio of 444.62% gauges short-term asset coverage for liabilities. The quick ratio (183.37%) assesses immediate liquidity, while the cash ratio (47.15%) indicates cash reserves.

Current Ratio444.62%
Quick Ratio183.37%
Cash Ratio47.15%

Profitability Ratios

KIDS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -15.00% underscores its earnings before tax deductions. The effective tax rate stands at 9.46%, revealing its tax efficiency. The net income per EBT, 90.54%, and the EBT per EBIT, 87.04%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -17.23%, we grasp its operational profitability.

Pretax Profit Margin-15.00%
Effective Tax Rate9.46%
Net Income per EBT90.54%
EBT per EBIT87.04%
EBIT per Revenue-17.23%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.45, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding183
Days of Inventory Outstanding867
Operating Cycle948.80
Days of Payables Outstanding152
Cash Conversion Cycle797
Receivables Turnover4.46
Payables Turnover2.40
Inventory Turnover0.42
Fixed Asset Turnover3.32
Asset Turnover0.37

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -1.20, and free cash flow per share, -2.09, depict cash generation on a per-share basis. The cash per share value, 2.09, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.17, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-1.20
Free Cash Flow per Share-2.09
Cash per Share2.09
Operating Cash Flow Sales Ratio-0.17
Free Cash Flow to Operating Cash Flow Ratio1.75
Cash Flow Coverage Ratio-2.80
Short Term Coverage Ratio-177.11
Capital Expenditure Coverage Ratio-1.33
Dividend Paid and Capex Coverage Ratio-1.33

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2.23%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.03, we discern the balance between debt and equity financing. The long-term debt to capitalization, 2.52%, and total debt to capitalization, 2.56%, ratios shed light on its capital structure. An interest coverage of -42.96 indicates its ability to manage interest expenses.

Debt Ratio2.23%
Debt Equity Ratio0.03
Long Term Debt to Capitalization2.52%
Total Debt to Capitalization2.56%
Interest Coverage-42.96
Cash Flow to Debt Ratio-2.80
Company Equity Multiplier1.18

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 6.56, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.92, reflects the portion of profit attributed to each share. The book value per share, 16.63, represents the net asset value distributed per share, while the tangible book value per share, 9.21, excludes intangible assets.

Revenue Per Share6.56
Net Income Per Share-0.92
Book Value Per Share16.63
Tangible Book Value Per Share9.21
Shareholders Equity Per Share16.63
Interest Debt Per Share1.04
Capex Per Share-0.84

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 21.62%, indicates top-line expansion, while the gross profit growth, 3.54%, reveals profitability trends. EBIT growth, -18.25%, and operating income growth, -18.25%, offer insights into operational profitability progression. The net income growth, -1767.25%, showcases bottom-line expansion, and the EPS growth, -1643.62%, measures the growth in earnings per share.

Revenue Growth21.62%
Gross Profit Growth3.54%
EBIT Growth-18.25%
Operating Income Growth-18.25%
Net Income Growth-1767.25%
EPS Growth-1643.62%
EPS Diluted Growth-1659.32%
Weighted Average Shares Growth9.52%
Weighted Average Shares Diluted Growth8.25%
Operating Cash Flow Growth-24.26%
Free Cash Flow Growth-44.76%
10-Year Revenue Growth per Share106.03%
5-Year Revenue Growth per Share43.21%
3-Year Revenue Growth per Share66.63%
10-Year Operating CF Growth per Share10.57%
5-Year Operating CF Growth per Share3.81%
3-Year Operating CF Growth per Share-16.23%
10-Year Net Income Growth per Share27.94%
5-Year Net Income Growth per Share3.33%
3-Year Net Income Growth per Share49.30%
10-Year Shareholders Equity Growth per Share588.09%
5-Year Shareholders Equity Growth per Share155.66%
3-Year Shareholders Equity Growth per Share27.88%
Receivables Growth39.58%
Inventory Growth35.37%
Asset Growth5.11%
Book Value per Share Growth-9.08%
Debt Growth2519.63%
R&D Expense Growth27.23%
SGA Expenses Growth4.79%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 727,912,757.27, captures the company's total value, considering both debt and equity. Income quality, 1.29, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.51, gauges operational efficiency, while the research and development to revenue, 6.86%, highlights investment in innovation. The ratio of intangibles to total assets, 37.43%, indicates the value of non-physical assets, and capex to operating cash flow, 70.19%, measures reinvestment capability.

Enterprise Value727,912,757.27
Income Quality1.29
Sales General and Administrative to Revenue0.51
Research and Development to Revenue6.86%
Intangibles to Total Assets37.43%
Capex to Operating Cash Flow70.19%
Capex to Revenue-12.76%
Capex to Depreciation-109.20%
Stock-Based Compensation to Revenue7.08%
Graham Number18.60
Return on Tangible Assets-7.46%
Graham Net Net3.91
Working Capital184,830,000
Tangible Asset Value208,764,000
Net Current Asset Value153,935,000
Average Receivables29,708,500
Average Payables11,899,500
Average Inventory92,021,500
Days Sales Outstanding85
Days Payables Outstanding84
Days of Inventory On Hand704

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.06, and the price to book ratio, 2.06, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.92, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -16.67, and price to operating cash flows, -28.02, gauge market valuation against cash flow metrics.

Price Book Value Ratio2.06
Price to Book Ratio2.06
Price to Sales Ratio4.92
Price Cash Flow Ratio-28.02
Price Earnings to Growth Ratio-1.94
Enterprise Value Multiple-67.41
Price Fair Value2.06
Price to Operating Cash Flow Ratio-28.02
Price to Free Cash Flows Ratio-16.67
Price to Tangible Book Ratio1.96
Enterprise Value to Sales4.89
Enterprise Value Over EBITDA-86.85
EV to Operating Cash Flow-26.91
Earnings Yield-2.85%
Free Cash Flow Yield-6.24%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of OrthoPediatrics Corp. (KIDS) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -34.782 in 2024.

What is the ticker symbol of OrthoPediatrics Corp. stock?

The ticker symbol of OrthoPediatrics Corp. stock is KIDS.

What is company IPO date?

IPO date of OrthoPediatrics Corp. is 2017-10-13.

What is company current share price?

Current share price is 33.490 USD.

What is stock market cap today?

The market cap of stock today is 796599838.000.

What is PEG ratio in 2024?

The current -1.936 is -1.936 in 2024.

What is the number of employees in 2024?

In 2024 the company has 247.